Quoin Pharmaceuticals Ltd... (QNRX)
NASDAQ: QNRX
· Real-Time Price · USD
7.15
-0.33 (-4.41%)
At close: Aug 18, 2025, 3:59 PM
7.07
-1.12%
After-hours: Aug 18, 2025, 04:10 PM EDT
-4.41% (1D)
| Bid | 7 |
| Market Cap | 4.21M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.44M |
| EPS (ttm) | 958.65 |
| PE Ratio (ttm) | 0.01 |
| Forward PE | -0.27 |
| Analyst | Buy |
| Ask | 7.8 |
| Volume | 9,333 |
| Avg. Volume (20D) | 11,774 |
| Open | 7.19 |
| Previous Close | 7.48 |
| Day's Range | 7.15 - 7.50 |
| 52-Week Range | 5.01 - 54.95 |
| Beta | 1.82 |
About QNRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol QNRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for QNRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+0%
QNRX stock has given up its prior gain. Quoin Phar...
Unlock content with
Pro Subscription
2 months ago
+0%
Quoin Pharmaceuticals shares are trading higher after the company announced it received FDA clearance to initiate a second whole-body QRX003 netherton syndrome clinical study.
